# A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy

> **NCT06383702** · PHASE3 · UNKNOWN · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 358 (estimated)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** pregabalin sustained-release tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06383702
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-15
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-15
- **Target enrollment:** 358 (ESTIMATED)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06383702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06383702, "A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06383702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*